Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36157986)
Watch
English
Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
editorial
0 references
title
Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
main subject
tuberculosis
1 reference
based on heuristic
inferred from title
author
Noton Kumar Dutta
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
Petros C Karakousis
series ordinal
2
object named as
Petros C Karakousis
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
14 October 2015
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
published in
Frontiers in Microbiology
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
volume
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
page(s)
1117
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
cites work
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Serum drug concentrations predictive of pulmonary tuberculosis outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
A physiologically based pharmacokinetic model of rifampin in mice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Worldwide emergence of extensively drug-resistant tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Mechanisms of drug resistance in Mycobacterium tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Structural mechanism for rifampicin inhibition of bacterial rna polymerase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 October 2017
Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
RpoB8, a rifampicin-resistant termination-proficient RNA polymerase, has an increased Km for purine nucleotides during transcription elongation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
2 July 2018
Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4604300
retrieved
23 September 2018
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26528265
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26528265
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The specific inhibition of the DNA-directed RNA synthesis by rifamycin
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26528265
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.3389/FMICB.2015.01117
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
PMC publication ID
4604300
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
PubMed publication ID
26528265
1 reference
stated in
Europe PubMed Central
PMC publication ID
4604300
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26528265%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
ResearchGate publication ID
283492928
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit